• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑病变的十年发病率及病情进展:比弗迪尔姆眼科研究

Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.

作者信息

Klein Ronald, Klein Barbara E K, Tomany Sandra C, Meuer Stacy M, Huang Guan-Hua

机构信息

Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin 53726-2397, USA.

出版信息

Ophthalmology. 2002 Oct;109(10):1767-79. doi: 10.1016/s0161-6420(02)01146-6.

DOI:10.1016/s0161-6420(02)01146-6
PMID:12359593
Abstract

PURPOSE

The aim of the study was to describe the 10-year incidence and progression of retinal drusen, retinal pigmentary abnormalities, and signs of late age-related maculopathy.

DESIGN

Population-based cohort study.

PARTICIPANTS

The study included 4926 persons, 43 to 86 years of age at the time of a baseline examination from 1988 through 1990, living in Beaver Dam, Wisconsin, of whom 3684 participated in a 5-year follow-up examination and 2764 participated in a 10-year follow-up.

METHODS

Characteristics of drusen and other lesions typical of age-related maculopathy were determined by grading stereoscopic color fundus photographs using the Wisconsin Age-Related Maculopathy Grading System.

MAIN OUTCOMES MEASURES

Incidence of drusen type and size, pigmentary abnormalities, geographic atrophy, and exudative degeneration.

RESULTS

The 10-year incidence of early age-related maculopathy was 12.1% and of late age-related maculopathy it was 2.1%. There was a statistically significant increased incidence of age-related maculopathy lesions with age (P < 0.05). Individuals 75 years of age or older at baseline had significantly (P < 0.01) higher 10-year incidences of the following characteristics than people 43 to 54 years of age: larger sized drusen (125 micro m-249 micro m, 26.3% vs. 3.3%; > or =250 micro m, 16.2% vs. 1.0%), soft indistinct drusen (22.2% vs. 2.2%), retinal pigment abnormalities (19.5% vs. 0.8%), exudative macular degeneration (4.1% vs. 0%), and pure geographic atrophy (3.1% vs. 0%). Compared with those with small numbers of only small, hard drusen (1-2), those with large numbers of only hard drusen (8 or more) had an increased 10-year incidence of both soft drusen (12.3% vs. 6.7%) and pigmentary abnormalities (4.9% vs. 1.7%). Eyes with soft indistinct drusen or retinal pigmentary abnormalities at baseline, were more likely to develop late age-related macular degeneration at follow-up than eyes without these lesions (15.1% vs. 0.4% and 20.0% vs. 0.8%, respectively).

CONCLUSIONS

These population-based estimates document the high incidence of signs of age-related maculopathy in people 75 years of age or older. Our findings demonstrate that large numbers of hard drusen predict the incidence of soft drusen and pigmentary abnormalities and that the presence of the latter lesions significantly increases the risk for the development of geographic atrophy and exudative macular degeneration.

摘要

目的

本研究旨在描述视网膜玻璃膜疣、视网膜色素异常及晚期年龄相关性黄斑病变体征的10年发病率及进展情况。

设计

基于人群的队列研究。

参与者

本研究纳入了4926人,他们在1988年至1990年基线检查时年龄为43至86岁,居住在威斯康星州比弗迪尔,其中3684人参与了5年随访检查,2764人参与了10年随访。

方法

使用威斯康星年龄相关性黄斑病变分级系统对立体彩色眼底照片进行分级,以确定玻璃膜疣及其他年龄相关性黄斑病变典型病变的特征。

主要观察指标

玻璃膜疣类型和大小、色素异常、地图样萎缩及渗出性变性的发病率。

结果

早期年龄相关性黄斑病变的10年发病率为12.1%,晚期年龄相关性黄斑病变为2.1%。年龄相关性黄斑病变病变的发病率随年龄增长有统计学显著增加(P < 0.05)。基线时75岁及以上的个体,以下特征的10年发病率显著高于43至54岁的人群(P < 0.01):较大尺寸的玻璃膜疣(125μm - 249μm,26.3%对3.3%;≥250μm,16.2%对1.0%)、软性边界不清的玻璃膜疣(22.2%对2.2%)、视网膜色素异常(19.5%对0.8%)、渗出性黄斑变性(4.1%对0%)及单纯地图样萎缩(3.1%对0%)。与仅有少量小而硬玻璃膜疣(1 - 2个)的人相比,仅有大量硬玻璃膜疣(8个或更多)的人软性玻璃膜疣(12.3%对6.7%)和色素异常(4.9%对1.7%)的10年发病率均增加。基线时具有软性边界不清玻璃膜疣或视网膜色素异常的眼睛,在随访时比无这些病变的眼睛更易发生晚期年龄相关性黄斑变性(分别为15.1%对0.4%和20.0%对0.8%)。

结论

这些基于人群的估计记录了75岁及以上人群中年龄相关性黄斑病变体征的高发病率。我们的研究结果表明,大量硬玻璃膜疣可预测软性玻璃膜疣和色素异常的发病率,而后两者病变的存在显著增加了发生地图样萎缩和渗出性黄斑变性的风险。

相似文献

1
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.年龄相关性黄斑病变的十年发病率及病情进展:比弗迪尔姆眼科研究
Ophthalmology. 2002 Oct;109(10):1767-79. doi: 10.1016/s0161-6420(02)01146-6.
2
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.年龄相关性黄斑病变的五年发病率和进展情况:比弗迪姆眼研究
Ophthalmology. 1997 Jan;104(1):7-21. doi: 10.1016/s0161-6420(97)30368-6.
3
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.年龄相关性黄斑变性的15年累积发病率:比弗迪尔姆眼科研究
Ophthalmology. 2007 Feb;114(2):253-62. doi: 10.1016/j.ophtha.2006.10.040.
4
14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study.年龄相关性黄斑病变的14年发病率、进展及视觉损害:哥本哈根市眼科研究
Ophthalmology. 2005 May;112(5):787-98. doi: 10.1016/j.ophtha.2004.11.040.
5
Prevalence of Age-related Maculopathy: The Beaver Dam Eye Study.年龄相关性黄斑病变的患病率:比弗大坝眼研究。
Ophthalmology. 2020 Apr;127(4S):S122-S132. doi: 10.1016/j.ophtha.2020.01.033.
6
Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study.10年期年龄相关性黄斑病变相关病变的位置:比弗迪姆眼研究
Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2135-42. doi: 10.1167/iovs.03-1085.
7
Prevalence of age-related maculopathy. The Beaver Dam Eye Study.年龄相关性黄斑病变的患病率。比弗迪姆眼研究。
Ophthalmology. 1992 Jun;99(6):933-43. doi: 10.1016/s0161-6420(92)31871-8.
8
The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study.虹膜颜色、头发颜色与皮肤对阳光的敏感性和年龄相关性黄斑病变10年发病率之间的关系:比弗迪尔姆眼科研究
Ophthalmology. 2003 Aug;110(8):1526-33. doi: 10.1016/s0161-6420(03)00539-6.
9
Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study.阳光与年龄相关性黄斑病变的10年发病率:比弗迪尔姆眼科研究
Arch Ophthalmol. 2004 May;122(5):750-7. doi: 10.1001/archopht.122.5.750.
10
The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.心血管疾病与年龄相关性黄斑病变的长期发病率之间的关联:比弗迪尔姆眼研究
Ophthalmology. 2003 Jun;110(6):1273-80. doi: 10.1016/S0161-6420(03)00599-2.

引用本文的文献

1
Impact of Donor and Host Age on Systemic Cell Therapy to Treat Age-Related Macular Degeneration.供体和宿主年龄对全身细胞治疗年龄相关性黄斑变性的影响。
Cells. 2025 Sep 1;14(17):1360. doi: 10.3390/cells14171360.
2
Advancing AMD screening with an offline, AI-powered smartphone-based fundus camera: A prospective, real-world clinical validation.使用基于人工智能的离线智能手机眼底相机推进年龄相关性黄斑变性筛查:一项前瞻性、真实世界的临床验证。
Eye (Lond). 2025 Jul 11. doi: 10.1038/s41433-025-03902-2.
3
Multimodal imaging biomarkers for progression from intermediate to advanced age-related macular degeneration (AMD): a 10-year prospective longitudinal cohort study from the University of Colorado AMD registry.
用于从中度到重度年龄相关性黄斑变性(AMD)进展的多模态成像生物标志物:一项来自科罗拉多大学AMD登记处的10年前瞻性纵向队列研究。
BMJ Open Ophthalmol. 2025 Apr 5;10(1):e002112. doi: 10.1136/bmjophth-2024-002112.
4
Drusen Disappearance After Retinal Detachment Repair.视网膜脱离修复术后玻璃膜疣消失
J Vitreoretin Dis. 2024 Sep 14:24741264241276603. doi: 10.1177/24741264241276603.
5
Macular Pigment Optical Density as a Measurable Modifiable Clinical Biomarker.黄斑色素密度作为一种可测量可调节的临床生物标志物。
Nutrients. 2024 Sep 27;16(19):3273. doi: 10.3390/nu16193273.
6
Recent Updates on the Diagnosis and Management of Age-Related Macular Degeneration.年龄相关性黄斑变性诊断与管理的最新进展
Mayo Clin Proc Innov Qual Outcomes. 2024 Jun 26;8(4):364-374. doi: 10.1016/j.mayocpiqo.2024.05.003. eCollection 2024 Aug.
7
The Total Macular Burden of Hyperreflective Foci and the Onset of Persistent Choroidal Hypertransmission Defects in Intermediate AMD.高度反光焦点的总黄斑负担与中间型 AMD 持续性脉络膜高透过性缺陷的发生。
Am J Ophthalmol. 2024 Nov;267:61-75. doi: 10.1016/j.ajo.2024.06.023. Epub 2024 Jun 27.
8
Switching from a Fixed Monthly Aflibercept Regimen to Bi-Monthly Brolucizumab in Refractory Cases of Neovascular Age-Related Macular Degeneration.在新生血管性年龄相关性黄斑变性难治性病例中,从每月一次的阿柏西普固定方案转换为每两个月一次的布罗芦izumab治疗。
J Clin Med. 2024 Jun 12;13(12):3434. doi: 10.3390/jcm13123434.
9
Differential gene expression between central and peripheral retinal regions in dogs and comparison with humans.犬中央和周边视网膜区域的差异基因表达及其与人类的比较。
Exp Eye Res. 2024 Aug;245:109980. doi: 10.1016/j.exer.2024.109980. Epub 2024 Jun 22.
10
One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment.既往贝伐珠单抗治疗后玻璃体内法西单抗注射治疗新生血管性年龄相关性黄斑变性的 1 年视力和解剖学结果。
Sci Rep. 2024 Apr 20;14(1):9087. doi: 10.1038/s41598-024-59894-8.